Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$96.34 - $112.38 $45.6 Million - $53.2 Million
473,672 New
473,672 $48.7 Million
Q4 2022

Feb 14, 2023

SELL
$62.39 - $113.8 $6.23 Million - $11.4 Million
-99,882 Reduced 10.82%
823,124 $93.7 Million
Q3 2022

Nov 07, 2022

SELL
$58.92 - $84.67 $24.1 Million - $34.6 Million
-408,831 Reduced 30.7%
923,006 $57.1 Million
Q2 2022

Aug 10, 2022

BUY
$79.4 - $116.36 $1.56 Million - $2.29 Million
19,643 Added 1.5%
1,331,837 $106 Million
Q1 2022

May 12, 2022

SELL
$86.42 - $109.81 $9.43 Million - $12 Million
-109,121 Reduced 7.68%
1,312,194 $138 Million
Q4 2021

Feb 11, 2022

SELL
$98.56 - $119.91 $9.4 Million - $11.4 Million
-95,381 Reduced 6.29%
1,421,315 $154 Million
Q3 2021

Nov 10, 2021

SELL
$91.91 - $110.37 $30 Million - $36 Million
-325,987 Reduced 17.69%
1,516,696 $166 Million
Q2 2021

Aug 11, 2021

SELL
$86.24 - $95.92 $50.4 Million - $56.1 Million
-584,637 Reduced 24.09%
1,842,683 $173 Million
Q1 2021

May 14, 2021

BUY
$71.83 - $95.48 $13.4 Million - $17.9 Million
187,241 Added 8.36%
2,427,320 $220 Million
Q4 2020

Feb 12, 2021

SELL
$67.0 - $84.39 $46 Million - $58 Million
-686,792 Reduced 23.47%
2,240,079 $169 Million
Q3 2020

Nov 12, 2020

BUY
$55.23 - $79.93 $41.6 Million - $60.2 Million
752,602 Added 34.61%
2,926,871 $229 Million
Q2 2020

Aug 12, 2020

BUY
$30.2 - $56.98 $9.17 Million - $17.3 Million
303,708 Added 16.24%
2,174,269 $120 Million
Q1 2020

May 11, 2020

SELL
$24.87 - $38.56 $416,696 - $646,072
-16,755 Reduced 0.89%
1,870,561 $55.4 Million
Q4 2019

Feb 07, 2020

SELL
$25.43 - $36.67 $15.7 Million - $22.7 Million
-617,886 Reduced 24.66%
1,887,316 $68.3 Million
Q3 2019

Nov 04, 2019

BUY
$23.0 - $27.97 $57.6 Million - $70.1 Million
2,505,202 New
2,505,202 $68.2 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.